Eric von Hofe

1.8k total citations
63 papers, 1.5k citations indexed

About

Eric von Hofe is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Eric von Hofe has authored 63 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 34 papers in Immunology and 19 papers in Oncology. Recurrent topics in Eric von Hofe's work include Immunotherapy and Immune Responses (31 papers), vaccines and immunoinformatics approaches (15 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Eric von Hofe is often cited by papers focused on Immunotherapy and Immune Responses (31 papers), vaccines and immunoinformatics approaches (15 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Eric von Hofe collaborates with scholars based in United States, Greece and Switzerland. Eric von Hofe's co-authors include Nikoletta L. Kallinteris, Minzhen Xu, Robert E. Humphreys, Constantin N. Baxevanis, Shyam Ramchandani, A. Robert MacLeod, Marc Pinard, Moshe Szyf, Paul Kleihues and Sonia A. Perez and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Eric von Hofe

62 papers receiving 1.4k citations

Peers

Eric von Hofe
T Nikaido Japan
Marat Alimzhanov United States
Norihito Kawasaki Japan
Suzanne Crawley United States
Josef Brüggen Switzerland
H D Royer Germany
Kerstin Siegmund Austria
Carlota Wolfenstein‐Todel Argentina
H. Peter Vollmers Germany
Marie Audette Canada
T Nikaido Japan
Eric von Hofe
Citations per year, relative to Eric von Hofe Eric von Hofe (= 1×) peers T Nikaido

Countries citing papers authored by Eric von Hofe

Since Specialization
Citations

This map shows the geographic impact of Eric von Hofe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric von Hofe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric von Hofe more than expected).

Fields of papers citing papers by Eric von Hofe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric von Hofe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric von Hofe. The network helps show where Eric von Hofe may publish in the future.

Co-authorship network of co-authors of Eric von Hofe

This figure shows the co-authorship network connecting the top 25 collaborators of Eric von Hofe. A scholar is included among the top collaborators of Eric von Hofe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric von Hofe. Eric von Hofe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hofe, Eric von, Yanping Yang, & Moonsoo M. Jin. (2023). Target selection and clinical chimeric antigen receptor T cell activity against solid tumors. SHILAP Revista de lepidopterología. 1(1). 29–43. 4 indexed citations
2.
Yang, Yanping, Janusz Puc, Yogindra Vedvyas, et al.. (2023). Inducible expression of interleukin-12 augments the efficacy of affinity-tuned chimeric antigen receptors in murine solid tumor models. Nature Communications. 14(1). 2068–2068. 18 indexed citations
3.
Yang, Yanping, Janusz Puc, Yogindra Vedvyas, et al.. (2021). Bispecific CAR T Cells against EpCAM and Inducible ICAM-1 Overcome Antigen Heterogeneity and Generate Superior Antitumor Responses. Cancer Immunology Research. 9(10). 1158–1174. 45 indexed citations
4.
Vedvyas, Yogindra, Yanping Yang, Irene M. Min, et al.. (2019). Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy. Scientific Reports. 9(1). 10634–10634. 66 indexed citations
5.
Mittendorf, Elizabeth A., Alexandros Ardavanis, James T. Symanowski, et al.. (2016). Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide AE37 vaccine in breast cancer patients to prevent recurrence. Annals of Oncology. 27(7). 1241–1248. 80 indexed citations
6.
Xu, Minzhen, Nikoletta L. Kallinteris, & Eric von Hofe. (2012). CD4+ T-cell activation for immunotherapy of malignancies using Ii-Key/MHC class II epitope hybrid vaccines. Vaccine. 30(18). 2805–2810. 16 indexed citations
7.
Hofe, Eric von. (2011). A New Ally against Cancer. Scientific American. 305(4). 66–71. 1 indexed citations
8.
Wambre, Erik, Mélodie Bonvalet, Bernard Maillère, et al.. (2010). Distinct characteristics of seasonal (Bet v 1) vs. perennial (Der p 1/Der p 2) allergen‐specific CD4+ T cell responses. Clinical & Experimental Allergy. 41(2). 192–203. 36 indexed citations
9.
Powell, D., et al.. (2009). Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination. Vaccine. 27(39). 5393–5401. 9 indexed citations
10.
Holmes, Jarrod P., Linda C. Benavides, Jeremy D. Gates, et al.. (2008). Results of the First Phase I Clinical Trial of the Novel Ii-Key Hybrid Preventive HER-2/neuPeptide (AE37) Vaccine. Journal of Clinical Oncology. 26(20). 3426–3433. 112 indexed citations
11.
Kallinteris, Nikoletta L., et al.. (2006). Ii-Key/MHC class II epitope hybrids: a strategy that enhances MHC class II epitope loading to create more potent peptide vaccines. Expert Opinion on Biological Therapy. 6(12). 1311–1321. 25 indexed citations
12.
13.
Xu, Minzhen, et al.. (2001). MHC Class II Allosteric Site Drugs: New Immunotherapeutics for Malignant, Infectious and Autoimmune Diseases*. Scandinavian Journal of Immunology. 54(1-2). 39–44. 18 indexed citations
14.
Xu, Minzhen, Gang Qiu, Zhong Jiang, Eric von Hofe, & Robert E. Humphreys. (2000). Genetic modulation of tumor antigen presentation. Trends in biotechnology. 18(4). 167–172. 18 indexed citations
15.
16.
Hofe, Eric von, Paul M. Newberne, & Ann R. Kennedy. (1991). Inhibition of N-nitrosomethylbenzylamine-induced esophageal neoplasms by the Bowman-Birk protease inhibitor. Carcinogenesis. 12(11). 2147–2150. 42 indexed citations
17.
Hofe, Eric von, et al.. (1990). Modulation of mouse fibroblast adipocyte differentiation by X-rays and TPA. Cancer Letters. 54(1-2). 9–15. 1 indexed citations
18.
Streeter, Anthony J., Raymond W. Nims, Lucy M. Anderson, et al.. (1990). Single-dose toxicokinetics ofN-nitrosomethylethylamine andN-nitrosomethyl (2,2,2-trideuterioethyl)amine in the rat. Archives of Toxicology. 64(2). 109–115. 1 indexed citations
19.
Schold, S. Clifford, Thomas P. Brent, Eric von Hofe, et al.. (1989). O6-Alkylguanine-DNA alkyltransferase and sensitivity to procarbazine in human brain-tumor xenografts. Journal of neurosurgery. 70(4). 573–577. 100 indexed citations
20.
Hofe, Eric von & Ann R. Kennedy. (1988). In vitro induction of O6-methylguanine-DNA methyltransferase in C3H/10T1/2 cells by X-rays is inhibited by nitrogen. Carcinogenesis. 9(4). 679–681. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T Nikaido Breakdown of academic impact, for papers by Marat Alimzhanov Breakdown of academic impact, for papers by Norihito Kawasaki Breakdown of academic impact, for papers by Suzanne Crawley Breakdown of academic impact, for papers by Josef Brüggen Breakdown of academic impact, for papers by H D Royer Breakdown of academic impact, for papers by Kerstin Siegmund Breakdown of academic impact, for papers by Carlota Wolfenstein‐Todel Breakdown of academic impact, for papers by H. Peter Vollmers Breakdown of academic impact, for papers by Marie Audette
Rankless by CCL
2026